Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model
Article first published online: 16 DEC 2004
Copyright © 2004 Wiley-Liss, Inc.
Journal of Cellular Physiology
Volume 203, Issue 2, pages 447–456, May 2005
How to Cite
Chujo, S., Shirasaki, F., Kawara, S., Inagaki, Y., Kinbara, T., Inaoki, M., Takigawa, M. and Takehara, K. (2005), Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model. J. Cell. Physiol., 203: 447–456. doi: 10.1002/jcp.20251
- Issue published online: 23 FEB 2005
- Article first published online: 16 DEC 2004
- Manuscript Accepted: 8 SEP 2004
- Manuscript Received: 25 JUL 2004
Skin fibrotic disorders such as systemic sclerosis (SSc) are characterized by an excessive production of extracellular matrix (ECM) and understood to develop under the influence of certain growth factors. Connective tissue growth factor (CTGF) is a cysteine-rich mitogenic peptide that is implicated in various fibrotic disorders and induced in fibroblasts after activation with transforming growth factor-β (TGF-β). To better understand the mechanisms of persistent fibrosis seen in SSc, we previously established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, TGF-β transiently induced subcutaneous fibrosis and serial injections of CTGF after TGF-β caused persistent fibrosis. To further define the mechanisms of skin fibrosis induced by TGF-β and CTGF in vivo, we investigated in this study, the effects of growth factors on the promoter activity of the proα2 (I) collagen (COL1A2) gene in skin fibrosis. For this purpose, we utilized transgenic reporter mice harboring the −17 kb promoter sequence of the mouse COL1A2 linked to either a firefly luciferase gene or a bacterial β-galactosidase gene. Serial injections of CTGF after TGF-β resulted in a sustained elevation of COL1A2 mRNA expression and promoter activity compared with consecutive injection of TGF-β alone on day 8. We also demonstrated that the number of fibroblasts with activated COL1A2 transcription was increased by serial injections of CTGF after TGF-β in comparison with the injection of TGF-β alone. Furthermore, the serial injections recruited mast cells and macrophages. The number of mast cells reached a maximum on day 4 and remained relatively high up to day 8. In contrast to the kinetics of mast cells, the number of macrophages was increased on day 4 and continued to rise during the subsequent consecutive CTGF injections until day 8. These results suggested that CTGF maintains TGF-β-induced skin fibrosis by sustaining COL1A2 promoter activation and increasing the number of activated fibroblasts. The infiltrated mast cells and macrophages may also contribute to the maintenance of fibrosis. © 2004 Wiley-Liss, Inc.